Skip to main content

A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants with Parkinson┬┐s Disease

Clinical Trial Grant
Duke Scholars

Administered By

Neurology, Movement Disorders

Awarded By

Biogen, Inc.

Start Date

October 11, 2022

End Date

December 31, 2026
 

Administered By

Neurology, Movement Disorders

Awarded By

Biogen, Inc.

Start Date

October 11, 2022

End Date

December 31, 2026